Carla Martins

Carla Martins is a Principal Scientist and Director at AstraZeneca since January 2019, specializing in drug development and discovery, with over 11 skills in the field. Previous experience includes serving as a Group Leader at the Medical Research Council from May 2011 to December 2018, where Carla led a cancer research lab focused on identifying and targeting molecular mechanisms in lung tumor progression, particularly in KRAS-driven cancers. Additional roles include Associate Scientist at the CRUK Cambridge Institute from September 2009 to April 2011, Postdoctoral Research Fellow at the University of California, San Francisco from October 2003 to June 2009, and PhD Student at The Netherlands Cancer Institute from October 1997 to August 2003.